Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Christoph Korpus, PhD, MBA, as Chief ...

MORE than 10 megawatts of electricity will soon start being supplied from a large solar farm expected to go into operation in ...

The University of Utah has formed a groundbreaking alliance with the Abundance Institute, a nonprofit that is focused on tackling societal and policy barriers facing emerging technologies. The U ...

One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...

Trump’s nominee to lead the Centers for Medicare and Medicaid Services is entangled in another potential conflict of interest ...

LC Nature Park will host a one-of-a-kind scavenger hunt in which participants look for antlers that elk have shed in the park ...

The new Food Strategy Advisory Board will look at improving diets - but a 24-hour junk food ad ban is ruled out ...

Researchers found no significant difference in overall cancer risk between red and white wine — and no type of wine was shown ...

Study results suggest that “telemedicine represents a unique opportunity to reduce time and travel burdens for patients with cancer considering clinical trials,” according to researchers.

Survey suggests bladder cancer incidence around five times higher for veterans under 70 compared to the general public ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical ...